92 related articles for article (PubMed ID: 23552952)
1. Are killer cell immunoglobulin-like receptor genes important for the prediction of kidney graft rejection?
Kuśnierczyk P
Arch Immunol Ther Exp (Warsz); 2013 Aug; 61(4):321-5. PubMed ID: 23552952
[TBL] [Abstract][Full Text] [Related]
2. KIR gene mismatching and KIR/C ligands in liver transplantation: consequences for short-term liver allograft injury.
Legaz I; López-Álvarez MR; Campillo JA; Moya-Quiles MR; Bolarín JM; de la Peña J; Salgado G; Gimeno L; García-Alonso AM; Muro M; Miras M; Alonso C; Álvarez-López MR; Minguela A
Transplantation; 2013 Apr; 95(8):1037-44. PubMed ID: 23478359
[TBL] [Abstract][Full Text] [Related]
3. Investigation of Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes to Predict the Occurrence of Acute Allograft Rejection after Kidney Transplantation.
Jafari D; Nafar M; Yekaninejad MS; Abdolvahabi R; Lesan Pezeshki M; Razaghi E; Amirzargar AA
Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):245-255. PubMed ID: 28732438
[TBL] [Abstract][Full Text] [Related]
4. KIR and Human Leukocyte Antigen Genotype Associated Risk of Cytomegalovirus Disease in Renal Transplant Patients.
Michelo CM; van der Meer A; Tijssen HJ; Zomer R; Stelma F; Hilbrands LB; Joosten I
Transplantation; 2015 Jul; 99(7):1506-13. PubMed ID: 25427165
[TBL] [Abstract][Full Text] [Related]
5. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
[TBL] [Abstract][Full Text] [Related]
6. KIR/HLA ligand incompatibility in kidney transplantation.
Kunert K; Seiler M; Mashreghi MF; Klippert K; Schönemann C; Neumann K; Pratschke J; Reinke P; Volk HD; Kotsch K
Transplantation; 2007 Dec; 84(11):1527-33. PubMed ID: 18091530
[TBL] [Abstract][Full Text] [Related]
7. KIR gene and KIR ligand analysis to predict graft rejection after renal transplantation.
Kreijveld E; van der Meer A; Tijssen HJ; Hilbrands LB; Joosten I
Transplantation; 2007 Oct; 84(8):1045-51. PubMed ID: 17989611
[TBL] [Abstract][Full Text] [Related]
8. Killer immunoglobulin-like receptor (KIR) and HLA genotypes affect the outcome of allogeneic kidney transplantation.
Nowak I; Magott-Procelewska M; Kowal A; Miazga M; Wagner M; Niepiekło-Miniewska W; Kamińska M; Wiśniewski A; Majorczyk E; Klinger M; Łuszczek W; Pawlik A; Płoski R; Barcz E; Senitzer D; Kuśnierczyk P
PLoS One; 2012; 7(9):e44718. PubMed ID: 23028591
[TBL] [Abstract][Full Text] [Related]
9. Putative role of KIR3DL1/3DS1 alleles and HLA-Bw4 ligands with end stage renal disease and long term renal allograft survival.
Prakash S; Sarangi AN; Alam S; Sonawane A; Sharma RK; Agrawal S
Gene; 2017 Dec; 637():219-229. PubMed ID: 28942035
[TBL] [Abstract][Full Text] [Related]
10. Low number of donor activating killer immunoglobulin-like receptors (KIR) genes but not KIR-ligand mismatch prevents relapse and improves disease-free survival in leukemia patients after in vivo T-cell depleted unrelated stem cell transplantation.
Kröger N; Binder T; Zabelina T; Wolschke C; Schieder H; Renges H; Ayuk F; Dahlke J; Eiermann T; Zander A
Transplantation; 2006 Oct; 82(8):1024-30. PubMed ID: 17060849
[TBL] [Abstract][Full Text] [Related]
11. Donor and recipient HLA/KIR genotypes do not predict liver transplantation outcome.
Moroso V; van der Meer A; Tilanus HW; Kazemier G; van der Laan LJ; Metselaar HJ; Joosten I; Kwekkeboom J
Transpl Int; 2011 Sep; 24(9):932-42. PubMed ID: 21672051
[TBL] [Abstract][Full Text] [Related]
12. Influence of killer immunoglobulin-like receptor/HLA ligand matching on achievement of T-cell complete donor chimerism in related donor nonmyeloablative allogeneic hematopoietic stem cell transplantation.
Sobecks RM; Ball EJ; Askar M; Theil KS; Rybicki LA; Thomas D; Brown S; Kalaycio M; Andresen S; Pohlman B; Dean R; Sweetenham J; Macklis R; Bernhard L; Cherni K; Copelan E; Maciejewski JP; Bolwell BJ
Bone Marrow Transplant; 2008 Apr; 41(8):709-14. PubMed ID: 18195688
[TBL] [Abstract][Full Text] [Related]
13. The killer immunoglobulin-like receptor (KIR) group A haplotype is associated with bronchiolitis obliterans syndrome after lung transplantation.
Kwakkel-van Erp JM; van de Graaf EA; Paantjens AW; van Ginkel WG; Schellekens J; van Kessel DA; van den Bosch JM; Otten HG
J Heart Lung Transplant; 2008 Sep; 27(9):995-1001. PubMed ID: 18765192
[TBL] [Abstract][Full Text] [Related]
14. Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.
Lorentzen AR; Karlsen TH; Olsson M; Smestad C; Mero IL; Woldseth B; Sun JY; Senitzer D; Celius EG; Thorsby E; Spurkland A; Lie BA; Harbo HF
Ann Neurol; 2009 Jun; 65(6):658-66. PubMed ID: 19630074
[TBL] [Abstract][Full Text] [Related]
15. Donor killer immunoglobulin-like receptor (KIR) genotype-patient cognate KIR ligand combination and antithymocyte globulin preadministration are critical factors in outcome of HLA-C-KIR ligand-mismatched T cell-replete unrelated bone marrow transplantation.
Yabe T; Matsuo K; Hirayasu K; Kashiwase K; Kawamura-Ishii S; Tanaka H; Ogawa A; Takanashi M; Satake M; Nakajima K; Tokunaga K; Inoko H; Saji H; Ogawa S; Juji T; Sasazuki T; Kodera Y; Morishima Y;
Biol Blood Marrow Transplant; 2008 Jan; 14(1):75-87. PubMed ID: 18158964
[TBL] [Abstract][Full Text] [Related]
16. Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation.
Giebel S; Nowak I; Dziaczkowska J; Czerw T; Wojnar J; Krawczyk-Kulis M; Holowiecki J; Holowiecka-Goral A; Markiewicz M; Kopera M; Karolczyk A; Kyrcz-Krzemien S; Kusnierczyk P
Eur J Haematol; 2009 Oct; 83(4):343-56. PubMed ID: 19500138
[TBL] [Abstract][Full Text] [Related]
17. Comparison of KIR gene content profiles revealed a difference between northern and southern Persians in the distribution of KIR2DS5 and its linked loci.
Solgi G; Ghafari H; Ashouri E; Alimoghdam K; Rajalingam R; Amirzargar A
Hum Immunol; 2011 Nov; 72(11):1079-83. PubMed ID: 21867738
[TBL] [Abstract][Full Text] [Related]
18. Analysis of KIR genes in HLA-identical sibling hematopoietic stem cell transplantation in Thai patients with leukemia.
Wongwuttisaroj N; Vejbaesya S; Chongkolwatana V; Issaragrisil S
J Med Assoc Thai; 2012 Oct; 95(10):1261-5. PubMed ID: 23193738
[TBL] [Abstract][Full Text] [Related]
19. [Study on the behavior of NK cell KIRs of donor/recipient pairs in HLA matched unrelated allo-HSCT].
Bao XJ; He J; Chen ZX; Wu DP; Yao L; Yuan XN; Cen JN; Qiu QC; Di WY; Zhang H; Zhang J; Zhou XH; Xu HX
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):510-3. PubMed ID: 18078124
[TBL] [Abstract][Full Text] [Related]
20. Divergences in KIR2D+ natural killer and KIR2D+CD8+ T-cell reconstitution following liver transplantation.
López-Álvarez MR; Campillo JA; Legaz I; Blanco-García RM; Salgado-Cecilia G; Bolarín JM; Gimeno L; Gil J; García-Alonso AM; Muro M; Alvarez-López MR; Miras M; Minguela A
Hum Immunol; 2011 Mar; 72(3):229-37. PubMed ID: 21215286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
